Skip to main content

Search Videos and More

Showing 1 - 12 of 12 results

ASCO 2023: Bladder Cancer Highlights Presented By Charlene Mantia, MD

ASCO 2023: Bladder Cancer Highlights Presented By Charlene Mantia, MD

The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the bladder cancer clinical updates you need to know from ASCO 2023.

ASCO 2023: Kidney Cancer Highlights Presented By Vincent (Wenxin) Chu, MD

ASCO 2023: Kidney Cancer Highlights Presented By Vincent (Wenxin) Chu, MD

The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the kidney cancer clinical updates you need to know from ASCO 2023.

ASCO 2023: Prostate Cancer Highlights Presented By Jacob Berchuck, MD

ASCO 2023: Prostate Cancer Highlights Presented By Jacob Berchuck, MD

The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the prostate cancer clinical updates you need to know from ASCO 2023.

2023 ASCO Highlights

2023 ASCO Highlights

Dana-Farber physician-scientists shared research and clinical advances at the 2023 Annual Meeting of the American Society of Clinical Oncologists (ASCO).

ASCO 2023: Breast Cancer Research Presented by Sara Tolaney, MD

ASCO 2023: Breast Cancer Research Presented by Sara Tolaney, MD

Data shows antibody-drug conjugate offers significant survival benefit for patients with HR-positive/HER2-negative metastatic breast cancer.

ASCO 2023: Treating NUT Carcinoma Research Presented by Jia Luo, MD

ASCO 2023: Treating NUT Carcinoma Research Presented by Jia Luo, MD

Dana-Farber's Jia Luo, MD, details on findings from the NUT Carcinoma Registry on initial chemotherapy for locally advanced and metastatic disease.

ASCO 2023: Breast Cancer Research Presented by Jennifer Ligibel, MD

ASCO 2023: Breast Cancer Research Presented by Jennifer Ligibel, MD

Women with breast cancer shed pounds thanks to telephone-based weight loss program, clinical trial finds.

ASCO 2023: Kidney Cancer Research Presented by Toni Choueiri, MD

ASCO 2023: Kidney Cancer Research Presented by Toni Choueiri, MD

We learn from negative study results as well as from positive ones. Phase 3 study by Dana-Farber's Toni Choueiri, MD, shows that rechallenge with PD-L1 inhibitors in second-line therapy for advanced kidney cancer has no benefit.

ASCO 2023: Breast Cancer Research Presented by Paolo Tarantino, MD

ASCO 2023: Breast Cancer Research Presented by Paolo Tarantino, MD

Data from more than 8,000 patients with stage 1A triple-negative breast cancer finds improved 5-year breast-cancer specific survival in those treated with adjuvant chemotherapy whose tumors measured between 1-2 cm.

ASCO 2023: Head And Neck Research Presented by Glenn Hanna, MD

ASCO 2023: Head And Neck Research Presented by Glenn Hanna, MD

Encouraging anti-tumor activity for patients with metastatic head & neck squamous cell carcinoma who are HPV-negative and treated with bifunctional EGFR/TGF-beta inhibitor BCA101 w/pembrolizumab.

ASCO 2023: Prostate Cancer Research Presented by Praful Ravi, MB BCHIR, MRCP

ASCO 2023: Prostate Cancer Research Presented by Praful Ravi, MB BCHIR, MRCP

ICECAP collaboration was the largest study looking at the prognostic value of PSA nadir in localized prostate cancer, finding a PSA level of less than 0.1 could provide an early prognosis signal.

ASCO 2023 Highlights

ASCO 2023 Highlights

Dana-Farber physician-scientists will share research and clinical advances at the 2023 Annual Meeting of the American Society of Clinical Oncologists (ASCO).